| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38ffd5c4f9dac1f7fdbf0b81da6af5f7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2017-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69416f63fcf58b68a3777f553d7d2f71 |
| publicationDate |
2017-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017207628-A1 |
| titleOfInvention |
Antibody for cancer treatment |
| abstract |
The present invention relates to an antibody that inhibits at least one immune checkpoint, having an Fc region modified relative to that of the parent antibody. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10882908-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-3075200-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021508444-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019115773-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10844119-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10513558-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111601821-A |
| priorityDate |
2016-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |